3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Respiratory Problems -

Apnea risk low in most infants with bronchiolitis

Respiratory ProblemsOct 19, 06

In infants presenting with bronchiolitis (inflammation of the lungs), the risk of apnea (brief pauses in breathing) is less than 3 percent, study findings suggest. However, the risk is higher in very young and preterm infants.

Dr. Marvin B. Harper and colleagues at Boston’s Children’s Hospital evaluated the cases of 691 infants admitted to their institution with bronchiolitis. Nineteen of the infants (2.7 percent) developed apnea, the researchers report in the Annals of Emergency Medicine.

The team developed, a priori, a list of risk criteria for identifying infants at high risk for apnea: those born full term but less than one month of age; those born preterm (less than 37 weeks gestation) and younger than 48 weeks post-conception; or those who have had a previous witnessed episode of apnea.

All 19 infants with apnea met these criteria, the investigators report.

“No infant classified as low risk subsequently developed apnea,” the team reports. Hence, the risk criteria had a sensitivity of 100 percent and a negative predictive value of 100 percent.

Harper and colleagues acknowledge that admitting an infant based on his risk criteria might lead to unnecessary hospitalizations, but this drawback is “likely outweighed by the serious consequences for discharging a patient who subsequently develops apnea.”

SOURCE: Annals of Emergency Medicine October 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Study shows treatment for genetically caused emphysema is effective
  New method enables drug target validation for COPD treatment
  Garlic extract could help cystic fibrosis patients fight infection
  New technique provides novel approach to diagnosing ciliopathies
  Innovative Experiment Aims to Boost Lung Transplants
  CPAP improves work productivity for sleep apnea patients
  New Mayo Software Identifies and Stratifies Risk Posed by Lung Nodules
  Researchers explore PKC role in lung disease
  Breathing program may held save newborns’ lives: studies
  Vitamin D Improves Exercise Outcomes in Patients with COPD
  CPAP improves daytime sleepiness even in patients with low levels of symptoms
  Anti-Clotting Agent Does Not Improve Outcomes of Patients with Severe Pneumonia

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site